Michael Brooks
President bij EDESA BIOTECH, INC.
Vermogen: 74 068 $ op 31-03-2024
Profiel
Michael Brooks is currently the President at Edesa Biotech, Inc. He previously worked as the Director of Business Development at Cipher Pharmaceuticals, Inc. from 2010 to 2015.
He also held positions at Edesa Biotech, Inc. (Old) and Edesa Biotech Research, Inc. In terms of education, Dr. Brooks holds an MBA from the Rotman School of Management and undergraduate and doctorate degrees from the University of Toronto.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EDESA BIOTECH, INC.
0.56% | 02-04-2024 | 17 669 ( 0.56% ) | 74 068 $ | 31-03-2024 |
Actieve functies van Michael Brooks
| Bedrijven | Functie | Begin |
|---|---|---|
| EDESA BIOTECH, INC. | President | 07-06-2019 |
Eerdere bekende functies van Michael Brooks
| Bedrijven | Functie | Einde |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01-01-2015 |
| Edesa Biotech Research, Inc. | Corporate Officer/Principal | - |
Edesa Biotech, Inc. (Old)
 Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | President | - |
Opleiding van Michael Brooks
| Rotman School of Management | Masters Business Admin |
| University of Toronto | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| EDESA BIOTECH, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Health Technology |
| Edesa Biotech Research, Inc. |
